The emergence of drug-resistant tuberculous meningitis represents one of the most formidable challenges facing modern medicine, with profound implications for patient outcomes, treatment protocols, and healthcare resource allocation. As multidrug-resistant and extensively drug-resistant tuberculosis strains continue to spread globally, the management of drug-resistant TBM requires specialized approaches that combine innovative therapeutic strategies with comprehensive diagnostic Read.